AMP-activated protein kinase α1β1γ1 heterotrimer (AMPK (α1β1γ1))

AMP-activated protein kinase (AMPK) α1β1γ1 heterotrimer is a cellular energy sensor composed of a catalytic α1 subunit, a scaffolding β1 subunit, and a regulatory γ1 subunit[1][3][7]. This serine/threonine kinase complex is highly conserved and plays a central role in maintaining cellular and organismal energy homeostasis by activating catabolic pathways and inhibiting anabolic, ATP-consuming processes in response to changes in cellular energy status[2][3][5][7]. AMPK is directly activated by an increase in the cellular AMP/ATP ratio, with allosteric effects mediated by nucleotide binding to the γ1 subunit, and further regulated by phosphorylation of the α1 subunit at Thr172 by the upstream kinases LKB1 and CaMKKβ[2][3]. The AMPK α1β1γ1 heterotrimer controls critical metabolic processes relevant to metabolic diseases, making it a well-validated therapeutic target, notably for type 2 diabetes and obesity, and is implicated in cancer biology and cardiovascular health[6][7]. Drugs like metformin and thiazolidinediones exert part of their therapeutic effects via AMPK activation, and several direct AMPK activators have been described as well[6][7].

Other names

AMP-activated protein kinase heterotrimerAMPK complex (α1β1γ1)5'-AMP-activated protein kinase (α1β1γ1)PRKAA1/PRKAB1/PRKAG1 complex

Allosteric activation by AMP (or mimetics) binding to γ1 subunit, leading to conformational change and activation of the catalytic α1 subunit; Phosphorylation at Thr172 site in α1 subunit (by upstream kinases such as LKB1 or CaMKKβ); Prevention of ATP-consuming biosynthetic processes; Stimulation of catabolic pathways to restore cellular energy levels